201. Breast cancer surveillance in patients treated by radiotherapy for Hodgkin’s lymphoma
- Author
-
E. Regini, G. Ghione, Giovanna Mariscotti, P. Gavarotti, E. Brignardello, Pier Paolo Campanino, A. Luparia, Manuela Durando, C. Alfieri, and Giovanni Gandini
- Subjects
Adult ,Oncology ,medicine.medical_specialty ,Neoplasms, Radiation-Induced ,medicine.medical_treatment ,Breast Neoplasms ,Disease ,Radiation Dosage ,Risk Assessment ,Breast cancer ,Risk Factors ,Internal medicine ,Antineoplastic Combined Chemotherapy Protocols ,Humans ,Medicine ,Radiology, Nuclear Medicine and imaging ,skin and connective tissue diseases ,Aged ,Retrospective Studies ,Aged, 80 and over ,medicine.diagnostic_test ,business.industry ,Cancer ,Retrospective cohort study ,Interventional radiology ,General Medicine ,Middle Aged ,Hodgkin's lymphoma ,medicine.disease ,Hodgkin Disease ,Magnetic Resonance Imaging ,Radiation therapy ,Relative risk ,Female ,business - Abstract
The authors evaluated the relative risk of developing radiation-induced breast cancer (BC) in women treated with radiotherapy for Hodgkin's disease (HD) and analysed the imaging features of these breast neoplasms.We retrospectively studied 54 women who had all undergone radiotherapy between 1980 and 2010 (median age, 36.6 years). Women aged ≤30 years were screened with clinical breast examination, ultrasound (US) and, if necessary, mammography; women30 years had clinical breast examination, US and mammography. Three women underwent magnetic resonance (MR) imaging as well.Mammography detected seven invasive breast cancers in 6/54 women (11.1%). Median age at diagnosis was 26.1 years for HD and 42.4 for breast cancer. Breast cancer was diagnosed following a median latent period from radiotherapy of 15.1 years. Mean radiation dose was 37.6 Gy in women who developed breast cancer and 31.3 Gy in the other women.In our study, women who were exposed to radiation for HD had a 6.2-fold higher risk of developing breast cancer than the general population. In consideration of the young age and high breast density, women aged ≤30 years should be monitored by US and MR imaging; women aged30 years should be monitored by US, mammography and, when necessary, MR imaging.
- Published
- 2013